Carregant...

Clinical Use of Dornase Alfa Is Associated with a Slower Rate of FEV(1) Decline in Cystic Fibrosis

OBJECTIVES: Randomized controlled trials of dornase alfa have shown forced expiratory volume in 1 second (FEV(1)) to improve in patients with cystic fibrosis (CF) but have not assessed change in the rate of lung function decline. We assessed the relationship of dornase alfa use and FEV(1) decline us...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Konstan, Michael W., Wagener, Jeffrey S., Pasta, David J., Millar, Stefanie J., Jacobs, Joan R., Yegin, Ashley, Morgan, Wayne J.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4109161/
https://ncbi.nlm.nih.gov/pubmed/21438174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ppul.21388
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!